All In Biotech

Free tool

FAERS Monitor: Selenious Acid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209379 or its brand name (Selenious Acid, Selenious Acid). Reports on generic versions are filed under their own applications.

Reports

12

Serious

11

92% of reports

Hospitalization

4

Death reported

1

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • plasma cell myeloma5
  • diarrhoea2
  • cerebral palsy1
  • cholangitis1
  • circumstance or information capable of leading to medication error1
  • fatigue1
  • hypersensitivity1
  • infection1
  • internal haemorrhage1
  • nausea1
  • neuropathy peripheral1
  • pneumonia1
  • product label confusion1
  • respiratory failure1
  • wrong dose1

Reports by year received

View as table
YearReports
20121
20141
20171
20201
20234
20242
20262

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,147 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cerebral palsy11846.9282.5460
wrong dose1725.3111.0180
product label confusion1300.846.074
cholangitis1282.843.370
plasma cell myelomaSignal5224.6115.0902
internal haemorrhage1153.423.537
circumstance or information capable of leading to medication error151.97.912
respiratory failure124.03.75
neuropathy peripheral118.42.84
infection112.11.92
hypersensitivity19.41.41
diarrhoea25.41.54
pneumonia15.40.81
fatigue12.30.30
nausea12.20.30

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.